Relay Therapeutics vs Revolution Medicines
RLAY and RVMD side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How RLAY and RVMD compare
Revolution Medicines is the larger company, worth 10 times as much as Relay Therapeutics ($41.0B against $4.0B).
Relay Therapeutics scores higher on the StockData Score (10 against 3 for Revolution Medicines), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | RLAY | RVMD |
|---|---|---|
| Size and price | ||
| Market cap | $4.0B | $41.0B |
| Share price | $18.35 | $191.31 |
| Change, 1 year | 151% | 230% |
| Change, 5 years | −48.3% | 468% |
| Beta (5Y) | 1.97 | 1.35 |
| Employees | 192 | 883 |
| StockData Score | ||
| Total score | 10 (better) | 3 |
| Valuation score | 0 | 0 |
| Growth score | 2 (better) | 1 |
| Performance score | 2 (better) | 0 |
| Health score | 6 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 389× | – |
| P/B | 4.5× (better) | 15.7× |
| FCF yield | – | −3.0% |
| Growth | ||
| Revenue growth (TTM) | 23.9% | – |
| Revenue growth, 5Y average | −28.6% | – |
| Profitability | ||
| Operating margin | −2999% | – |
| Net margin | −2764% | – |
| Return on equity | −36.8% (better) | −79.1% |
| Return on invested capital | −37.1% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −27.4× |
| Current ratio | 18.27 (better) | 11.38 |
| Altman Z-score | 28.05 (better) | 12.82 |
| Piotroski F-score | 4 (better) | 2 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 113% | 105% |
| Held by insiders | 24.5% | 5.3% |
| Insider net buying, 12 months | −$128M (better) | −$153M |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 28.2% | – |
Go deeper
- RLAY stock overview
- RLAY income statement
- RLAY valuation and score
- RVMD stock overview
- RVMD income statement
- RVMD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.